Article
A pilot study of expanded newborn screening for 573 genes related to severe inherited disorders in China: results from 1,127 newborns
1 Sept 2020
Abstract excerpt
Background: Newborn screening (NBS) in China is mainly aimed at detecting biochemical levels of metabolites in the blood, which may generate false-positive/negative results. Current biochemical NBS includes tandem mass spectrometry (MS/MS) screening for metabolites as well as phenylalanine (Phe), thyroid-stimulating hormone (TSH), 17-α-hydroxyprogesterone (17-OHP), and glucose-6-phosphate dehydrogenase (G6PD)...
Topics
Join the communities discussing this publication.
